![Rajkumar Kannan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rajkumar Kannan
Director Ejecutivo en I-MAB .
Cargos activos de Rajkumar Kannan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AMRYT PHARMA PLC | Director/Miembro de la Junta | 05/08/2021 | - |
I-MAB | Director/Miembro de la Junta | 22/06/2023 | - |
Director Ejecutivo | 22/06/2023 | - | |
I-MAB Biopharma Co., Ltd.
![]() I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Historial de carrera de Rajkumar Kannan
Antiguos cargos conocidos de Rajkumar Kannan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
AERIE PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 20/12/2021 | 21/11/2022 |
Director Ejecutivo | 20/12/2021 | 21/11/2022 | |
CHIASMA, INC. | Director/Miembro de la Junta | 17/06/2019 | 05/08/2021 |
Director Ejecutivo | 17/06/2019 | 05/08/2021 | |
Presidente | 19/01/2021 | 05/08/2021 | |
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Corporate Officer/Principal | 01/07/2018 | 01/06/2019 |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Ventas & Marketing | 01/03/2004 | 01/06/2014 |
MERCK KGAA | Corporate Officer/Principal | 01/03/1995 | 01/02/2004 |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 05/08/2021 | - |
Formación de Rajkumar Kannan.
East Carolina University | Masters Business Admin |
University of Madras | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Reino Unido | 3 |
India | 2 |
Operativa
Director/Board Member | 6 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 2 |
Sectorial
Health Technology | 10 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MERCK KGAA | Health Technology |
I-MAB | Health Technology |
Empresas privadas | 7 |
---|---|
Chiasma, Inc.
![]() Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Chiasma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of oral forms of therapies that are available by injection. Its products include octreotide capsules. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Newton Center, MA. | Health Technology |
Kiniksa Pharmaceuticals Ltd.
![]() Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
Boehringer Ingelheim Corp.
![]() Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Amryt Pharma Holdings Ltd.
![]() Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Aerie Pharmaceuticals, Inc.
![]() Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Amryt Pharma Plc
![]() Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded in August 2015 and is headquartered in Dublin, Ireland. | Health Technology |
I-MAB Biopharma Co., Ltd.
![]() I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
- Bolsa de valores
- Insiders
- Rajkumar Kannan
- Experiencia